Reach Us +44-1904-929220
Cancer Bioinformatics, A Potential Way For Prediction Of Chemotherapeutic Responses In Clinics | 3655

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cancer bioinformatics, a potential way for prediction of chemotherapeutic responses in clinics

2nd World Congress on Biomarkers & Clinical Research

Da-Yong Lu, Ting-Ren Lu and Xue-Liang Chen

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.2

Cancers are diff erent etiological diseases with same characteristics of unlimited cell reproductions caused by the abnormalities of genetic molecules in human cells. Bioinformatics plays important role in revealing these abnormalities of genetic molecules for the importance of cancer diagnostics, prognostics and most important, therapeutics. It is a way of profound signifi cance not only with quickness and high-throughput, but also of potential quantitative value of prediction for drug responses and use details. It is the fastest-growing area in recent cancer research. However, many technical and economic drawbacks impede us from reaching the goal of therapeutic benefi ts in clinics at current stage and will continual to be in the case in nearly future. We in several years before suggest a way of combination of drug sensitivity tests and mathematical computation, bioinformatics to make it more adequate and available. Adhering to this policy, improving of bioinformatics systems is especially important for the benefi ts of future individual therapy. In general, presently bioinformatics requires rigorous discipline and reasonable routine to make it real work in future clinical practices. Th eir gaining of popularity and new breakthrough are largely dependent on the progression of these disciplines. Aft er introducing the general backgrounds of current bioinformatics application in cancer research, here we represent our insights and suggestions into the approach, especially their relations with genome-wide analysis, drug sensitivity tests and mathematics-related problems.
LU Da-Yong, oc/professor; ad/1288 Shangda Rd, 95-202, Shanghai200444, PR China; ed/ph D Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 2005, MS, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 1986, BS, Shanghai Medical University (Now Fudan University affi liated),1982; Now School of Life Sciences, Shanghai University, Shanghai200444, PR China. Undergo the studies of cancer pathology, biochemistry pharmacology and clinical therapeutics from 1982 and some hypotheses in AIDS and neural science in 2007. More than 20 scientifi c articles have been published in international journals.
Relevant Topics